132 related articles for article (PubMed ID: 31999978)
1. Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.
Jarrar YB; Kim DH; Lee SJ; Shin JG
Prostaglandins Leukot Essent Fatty Acids; 2020 Feb; 153():102055. PubMed ID: 31999978
[TBL] [Abstract][Full Text] [Related]
2. Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation.
Jarrar YB; Cha EY; Seo KA; Ghim JL; Kim HJ; Kim DH; Lee SJ; Shin JG
J Lipid Res; 2014 Nov; 55(11):2334-42. PubMed ID: 25249502
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs.
Knights KM; Winner LK; Elliot DJ; Bowalgaha K; Miners JO
Br J Clin Pharmacol; 2009 Sep; 68(3):402-12. PubMed ID: 19740398
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes.
Mano Y; Usui T; Kamimura H
Eur J Clin Pharmacol; 2007 Feb; 63(2):211-6. PubMed ID: 17200831
[TBL] [Abstract][Full Text] [Related]
5. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes.
Kuehl GE; Lampe JW; Potter JD; Bigler J
Drug Metab Dispos; 2005 Jul; 33(7):1027-35. PubMed ID: 15843492
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3beta-glucuronidation in human liver microsomes.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2005 Jan; 26(1):35-9. PubMed ID: 15593333
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.
Sten T; Finel M; Ask B; Rane A; Ekström L
Steroids; 2009 Nov; 74(12):971-7. PubMed ID: 19643121
[TBL] [Abstract][Full Text] [Related]
8. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2006 Jan; 27(1):1-6. PubMed ID: 16278927
[TBL] [Abstract][Full Text] [Related]
10. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
Gaganis P; Miners JO; Knights KM
Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
[TBL] [Abstract][Full Text] [Related]
11. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
Joo J; Kim YW; Wu Z; Shin JH; Lee B; Shon JC; Lee EY; Phuc NM; Liu KH
Biopharm Drug Dispos; 2015 May; 36(4):258-64. PubMed ID: 25522350
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
[TBL] [Abstract][Full Text] [Related]
13. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
14. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
15. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
Mano Y; Usui T; Kamimura H
Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.
King C; Tang W; Ngui J; Tephly T; Braun M
Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
Wang H; Yuan L; Zeng S
Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
[TBL] [Abstract][Full Text] [Related]
18. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
[TBL] [Abstract][Full Text] [Related]
19. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases.
Turgeon D; Chouinard S; Belanger P; Picard S; Labbe JF; Borgeat P; Belanger A
J Lipid Res; 2003 Jun; 44(6):1182-91. PubMed ID: 12639971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
